OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Maria Tsamou

1 Projects | 1 Researchers | $262,699 Invested

2022

ToxGenSolutions BV

Maria Tsamou, PhD

Validation of a set of peripheral biomarkers with the potential to identify individuals at risk of developing Alzheimer's disease at the cross-section between early environmental neurotoxicity and prodromal Alzheimer's disease.

  • Funding Amount: $262,699
  • Organization Type: Biotechnology/For Profit
  • Program: Diagnostics Accelerator
  • Target: Epigenetics
  • Status: Closed